Latest stories on CLLS
Cellectis S.A. (CLLS) Discusses Strategic Transformation and In Vivo Gene Editing Pipeline Update Transcript
Seeking Alpha63 · neutralproduct/pr
At a glance: stocks gapping down premarket
Seeking Alpha34 · bearishgeneral
Cellectis Announces Strategic Transformation To In Vivo Gene Editing Company
Business Insider65 · bullishproduct/pr
Cellectis Announces Strategic Transformation To In Vivo Gene Editing Company
GlobeNewswire65 · bullishproduct/pr
Cellectis Plans September 14 Business Update Webcast for Global Investors
TipRanks55 · neutralgeneral
Cellectis GAAP EPS of -$0.39, revenue of $14.45M
Business Insider28 · bearishearnings
Cellectis to Host Conference Call and Webcast on September 14 to Provide a Business Update
StockTitan50 · neutralgeneral
Cellectis to Host Conference Call and Webcast on September 14 to Provide a Business Update
GlobeNewswire50 · neutralgeneral
Cellectis to Host Conference Call and Webcast on September 14 to Provide a Business Update
Business Insider50 · neutralgeneral
Cellectis Updates Share Capital and Voting Rights as of August 31, 2026
TipRanks50 · neutralgeneral
Cellectis Announces Participation in Upcoming Investor Conferences
Business Insider56 · neutralgeneral
Cellectis Announces Participation in Upcoming Investor Conferences
GlobeNewswire56 · neutralgeneral
Cellectis: 'Hold' On Lasme-Cel Q4 2026 Catalyst And Eti-Cel Backup Candidate
Seeking Alpha56 · neutralanalyst
Cellectis reports Q2 adjusted EPS (35c) vs (40c) last year
The Fly56 · neutralearnings
Cellectis GAAP EPS of -$0.22 beats by $0.04, revenue of $6.9M misses by $3.93M
Seeking Alpha53 · neutralearnings
Cellectis Reports Financial Results for the Second Quarter 2026
StockTitan50 · neutralearnings
Monthly information on share capital and company voting rights
StockTitan50 · neutralgeneral
Cellectis to Report Second Quarter Financial Results on August 6, 2026
StockTitan50 · neutralgeneral
Cellectis to Report Second Quarter Financial Results on August 6, 2026
Business Insider50 · neutralgeneral
Cellectis to Report Second Quarter Financial Results on August 6, 2026
GlobeNewswire50 · neutralgeneral
Monthly information on share capital and company voting rights | CLLS Stock News
StockTitan50 · neutralgeneral
Cellectis Reports Results from Shareholders Meeting Held on June 25, 2026 | CLLS Stock News
StockTitan50 · neutralgeneral
Cellectis Unveils Strong Early CAR-T Data for Lasme-cel and Eti-cel at EHA 2026
TipRanks73 · bullishproduct/pr
Cellectis Presents Final Phase 1 Results of Lasme-cel and Preliminary Results on Eti-cel at EHA 2026 Congress | CLLS Stock News
StockTitan67 · bullishproduct/pr